Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 1





Antitumor Activities of Interleukin-27 on Melanoma

, 10(1): 41 - 46

Hiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, Mingli Xu, Izuru Mizoguchi, Takayuki Yoshimoto and Chikako Nishigori


DOI: 10.2174/187153010790827920




The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches

, 10(1): 71 - 82

Benoit Stijlemans, Ann Vankrunkelsven, Guy Caljon, Viki Bockstal, Martin Guilliams, Tom Bosschaerts, Alain Beschin, Geert Raes, Stefan Magez and Patrick De Baetselier


DOI: 10.2174/187153010790827966





Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.15

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi



Related Journals

Related eBooks

eBooks Catalog